Lynell Klassen is a Rheumatology/Immunology physician affiliated with VA Nebraska Western Iowa Health Care System. OpenAlex indexes 178 publications with 6,533 citations (h-index 44).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
27 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
36.4%Folate Analog Metabolic Inhibitor20.7%Methotrexate100%Part D≥74 patientsNonsteroidal Anti-inflammatory Drug9.8%Celecoxib100%Part D≥30 patients+ 3 more classes in this area
Metabolism & gastrointestinal
28.4%Corticosteroid19.8%Prednisone100%Part D≥85 patientsAntidiarrheal microorganisms4.2%Folic Acid100%Part D≥18 patients+ 2 more classes in this area
Antiparasitic
16.8%Antimalarial16.8%Hydroxychloroquine Sulfate100%Part D≥69 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1989–2020 per NIH RePORTER. The latest:
- Great Plains IDeA-CTR-Professional Development Core
University of Nebraska Medical Center
FY2020$1,039,043U54GM115458 - Great Plains IDeA-CTR-Professional Development Core
University of Nebraska Medical Center
FY2019$1,039,043U54GM115458 - Great Plains IDeA-CTR-Professional Development Core
University of Nebraska Medical Center
FY2018$997,441U54GM115458
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”